Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Studies have revealed a robust and independent correlation between chronic kidney disease (CKD) and cardiovascular (CV) events, including death, heart failure, and myocardial infarction. Recent clinical trials extend this range of adverse CV events, including malignant ventricular arrhythmias and su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Márcio Galindo Kiuchi, Jan K. Ho, Janis Marc Nolde, Leslie Marisol Lugo Gavidia, Revathy Carnagarin, Vance B. Matthews, Markus P. Schlaich
Formato:	Artículo
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020-01-01
Colección:	Frontiers in Physiology
Materias:	chronic kidney disease sympathetic nervous system hypertension left ventricular hypertrophy sudden cardiac death ventricular remodeling
Acceso en línea:	https://www.frontiersin.org/article/10.3389/fphys.2019.01546/full

Ejemplares similares

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
por: Janis M. Nolde, et al.
Publicado: (2021-08-01)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
por: Revathy Carnagarin, et al.
Publicado: (2019-01-01)

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective
por: Márcio Kiuchi, et al.
Publicado: (2019-12-01)

The effect of bilateral cardiac sympathetic denervation for refractory ventricular tachycardia in ischemic cardiomyopathy
por: Yuko Miki, et al.
Publicado: (2020-06-01)

Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?
por: Márcio G. Kiuchi, et al.
Publicado: (2016-03-01)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
por: Lakshini Y. Herat, et al.
Publicado: (2018-01-01)

Microvascular changes at different stages of chronic kidney disease
por: Dennis Kannenkeril, et al.
Publicado: (2021-02-01)

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation
por: Veronica Dusi, et al.
Publicado: (2021-01-01)

Device-based approaches for renal nerve ablation for hypertension and beyond
por: Alicia Ann Thorp, et al.
Publicado: (2015-07-01)

Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health
por: Leslie Marisol Lugo‐Gavidia, et al.
Publicado: (2022-06-01)

Sudden Cardiac Death and Idiopathic Ventricular Arrhythmias
por: Vries Lennart de, et al.
Publicado: (2015-12-01)

Transgenic models of cardiac arrhythmias and sudden death
por: Carol Ann eRemme
Publicado: (2013-03-01)

The Schlager mouse as a model of altered retinal phenotype
por: Lakshini Y Herat, et al.
Publicado: (2020-01-01)

Evidence of Ventricular Arrhythmogenicity and Cardiac Sympathetic Hyperinnervation in Early Cirrhotic Cardiomyopathy
por: Shin-Huei Liu, et al.
Publicado: (2021-12-01)

Efficacy and safety of cardiac sympathetic denervation for refractory ventricular arrhythmias: Experience of a Colombian hospital
por: Nicolas Arredondo-Mora, et al.
Publicado: (2024-03-01)

Cardiac Sympathetic Denervation in Channelopathies
por: Veronica Dusi, et al.
Publicado: (2019-03-01)

Sympathetic Activation and Arrhythmogenesis after Myocardial Infarction: Where Do We Stand?
por: Konstantinos C. Zekios, et al.
Publicado: (2021-05-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
por: P.C. Brum, et al.
Publicado: (2011-09-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
por: P.C. Brum, et al.
Publicado: (2011-09-01)

Effects of Renal Denervation on Sympathetic Activation, Blood Pressure and Glucose Metabolism in Patients with Resistant Hypertension
por: Markus Peter Schlaich, et al.
Publicado: (2012-02-01)

Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?
por: Philipp Sasse, et al.
Publicado: (2019-06-01)

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
por: D. S. Lebedev, et al.
Publicado: (2021-08-01)

Case Report: The unrelenting journey—successful resolution of catecholaminergic polymorphic ventricular tachycardia (CPVT) through right cardiac sympathetic denervation in a teenager after left cardiac sympathetic denervation
por: Hei-To Leung, et al.
Publicado: (2024-12-01)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Janis M. Nolde, et al.
Publicado: (2021-01-01)

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmia in Continuous-Flow Left Ventricular Assist Device
por: Peter P. Vlismas, MD, et al.
Publicado: (2021-03-01)

Comments on 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Ali Deniz, et al.
Publicado: (2016-02-01)

Editorial: The role of sex in cardiac arrhythmias and sudden cardiac death
por: Matias E. Pollevick, et al.
Publicado: (2023-03-01)

Renal sympathetic denervation assisted treatment of electrical storm due to polymorphic ventricular tachycardia in a patient with cathecolaminergic polymorphic ventricular tachycardia
por: Tolga Aksu, et al.
Publicado: (2017-07-01)

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
por: Alicia A. Thorp, et al.
Publicado: (2015-01-01)

Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia in the light of the medical situation in Japan
por: Masayoshi Mori, et al.
Publicado: (2024-08-01)

Acute hemodynamics of cardiac sympathetic denervation
por: Kunal Sinkar, et al.
Publicado: (2020-11-01)

Central sympathetic activation and arrhythmogenesis during acute myocardial infarction: modulating effects of endothelin-B receptors
por: Theofilos M Kolettis, et al.
Publicado: (2015-02-01)

Sudden cardiac death in patients with nonischemic cardiomyopathy
por: Brian P. Betensky, et al.
Publicado: (2014-01-01)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
por: Revathy Carnagarin, et al.
Publicado: (2021-07-01)

Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58%
por: Toshihiko Goto, et al.
Publicado: (2022-06-01)

Alcohol Ablation for Cardiac Arrhythmias: Is it Time to Drown the Arrhythmias?
por: Anandaraja Subramanian, MD, DM, FCE
Publicado: (2012-07-01)

QUANTIFICATION OF ELECTROCARDIOGRAM RHYTHMICITY TO DETECT LIFE THREATENING CARDIAC ARRHYTHMIAS USING SPECTRAL ENTROPY
por: CHANDRAKAR KAMATH
Publicado: (2013-10-01)

RISK STRATIFICATION OF SUDDEN CARDIAC DEATH IN EARLY REPOLARIZATION SYNDROME
por: Shpak N. V., et al.
Publicado: (2019-11-01)

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
por: Jia Liao, et al.
Publicado: (2024-02-01)

Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome
por: Elisabeth Annie Lambert, et al.
Publicado: (2011-08-01)